These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25493603)

  • 41. The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV.
    Gopalappa C; Stover J; Shaffer N; Mahy M
    AIDS; 2014 Jan; 28 Suppl 1():S5-14. PubMed ID: 24468947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Anaesthesia and intensive care characteristics in HIV-infected pregnant patients receiving the antiretroviral therapy].
    Krugova LV; Vartanov VIa; Vartanova IV; Shakhovskaia IN; Khutorskaia NN; Lapteva IV
    Anesteziol Reanimatol; 2010; (6):32-6. PubMed ID: 21400795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in a resource-limited setting.
    Shah M; Johns B; Abimiku A; Walker DG
    AIDS; 2011 May; 25(8):1093-102. PubMed ID: 21505317
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lessons from the 11th conference on retroviruses and opportunistic infections.
    Laurence J
    AIDS Read; 2004 Apr; 14(4):151-3. PubMed ID: 15116693
    [No Abstract]   [Full Text] [Related]  

  • 45. HIV drug resistance and mother-to-child transmission of HIV.
    Weidle PJ; Nesheim S
    Clin Perinatol; 2010 Dec; 37(4):825-42, x. PubMed ID: 21078453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
    Martin F; Taylor GP
    J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Children. Mother-to-infant ART may negatively affect heart.
    AIDS Policy Law; 2015 Feb; 30(3):1. PubMed ID: 26094265
    [No Abstract]   [Full Text] [Related]  

  • 49. More good news on reducing the incidence of maternal-fetal transmission of HIV and simplifying HAART.
    Boyle BA
    AIDS Read; 1999 Oct; 9(7):450-1, 469. PubMed ID: 12737135
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation and management of the infant exposed to HIV-1 in the United States.
    Havens PL; Mofenson LM;
    Pediatrics; 2009 Jan; 123(1):175-87. PubMed ID: 19117880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Inappropriate combinations of antiretroviral drugs].
    Machala L; Cerný R
    Klin Mikrobiol Infekc Lek; 2004 Oct; 10(5):241-3. PubMed ID: 15558454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of 4 weeks' neonatal antiretroviral prophylaxis as a component of a prevention of mother-to-child transmission program in a resource-rich setting.
    Ferguson W; Goode M; Walsh A; Gavin P; Butler K
    Pediatr Infect Dis J; 2011 May; 30(5):408-12. PubMed ID: 21266939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Teratogenicity risk of antiretroviral therapy in pregnancy.
    Watts DH
    Curr HIV/AIDS Rep; 2007 Aug; 4(3):135-40. PubMed ID: 17883999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Tolerance of antiretroviral drugs during pregnancy].
    Blanche S; Warszawski J
    Med Sci (Paris); 2013 Apr; 29(4):383-8. PubMed ID: 23621933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aggressive worsening of Sézary syndrome during early antiretroviral therapy.
    Lehloenya RJ; Shebe K; Hlela C; Dlamini S; Mankahla A; Lapiner V; Meintjes G; Todd G
    AIDS; 2013 Mar; 27(6):1035-1036. PubMed ID: 23698068
    [No Abstract]   [Full Text] [Related]  

  • 56. Key Principles of Antiretroviral Pharmacology.
    Dionne B
    Infect Dis Clin North Am; 2019 Sep; 33(3):787-805. PubMed ID: 31395145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is "option B+" also being adopted in pregnant women in high-income countries? Temporal trends from a national study in Italy.
    Floridia M; Guaraldi G; Ravizza M; Tibaldi C; Pinnetti C; Maccabruni A; Molinari A; Liuzzi G; Alberico S; Meloni A; Rizzi L; Dalzero S; Tamburrini E;
    Clin Infect Dis; 2015 Jan; 60(1):159-61. PubMed ID: 25230994
    [No Abstract]   [Full Text] [Related]  

  • 58. [Simplification of the antiretroviral regimens. A need to guarantee the long-term control of HIV infection].
    Barreiro García P; Soriano Vázquez V
    Rev Clin Esp; 2004 Apr; 204(4):212-4. PubMed ID: 15104931
    [No Abstract]   [Full Text] [Related]  

  • 59. HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review.
    Lambert CT; Sandesara PB; Hirsh B; Shaw LJ; Lewis W; Quyyumi AA; Schinazi RF; Post WS; Sperling L
    HIV Med; 2016 Jun; 17(6):411-24. PubMed ID: 26611380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Issues of prematurity and HIV infection.
    Mirpuri J; Jain L
    Clin Perinatol; 2010 Dec; 37(4):887-905, xi. PubMed ID: 21078457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.